Literature DB >> 24138785

Immune-mediated colitis: important to recognize and treat.

Christine Pocha1, James Roat2, Kimberly Viskocil2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24138785     DOI： 10.1016/j.crohns.2013.09.019

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  3 in total

1.  Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis.

Authors:  Andrew P Wright; Marc S Piper; Shrinivas Bishu; Ryan W Stidham
Journal:  Aliment Pharmacol Ther       Date:  2019-04-29       Impact factor: 8.171

Review 2.  Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.

Authors:  Christopher Ma; John K MacDonald; Tran M Nguyen; Niels Vande Casteele; Bryan Linggi; Pavine Lefevre; Yinghong Wang; Brian G Feagan; Vipul Jairath
Journal:  Dig Dis Sci       Date:  2021-03-26       Impact factor: 3.199

3.  Comment on "Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy".

Authors:  Konstantinos Argyriou; Athanasios Kotsakis
Journal:  World J Clin Cases       Date:  2022-08-16       Impact factor: 1.534
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.